TrialBMC cancer2024

LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.

Cornelis M van Tilburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.